These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1284 related items for PubMed ID: 17766723

  • 21. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K, Nakatsuka A, Akeboshi M, Shiraki K, Nakano T, Takeda K.
    Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Hwang YJ, Kim YI.
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [Abstract] [Full Text] [Related]

  • 24. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ.
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [Abstract] [Full Text] [Related]

  • 25. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
    Kobayashi M, Ikeda K, Kawamura Y, Yatsuji H, Hosaka T, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Kumada H.
    Cancer; 2009 Feb 01; 115(3):571-80. PubMed ID: 19117347
    [Abstract] [Full Text] [Related]

  • 26. [Influencing factors for intrahepatic distant recurrence of liver cancer after radiofrequency ablation].
    Luo JT, Wei X, Zhou HY, Li Q.
    Zhonghua Wai Ke Za Zhi; 2009 Oct 15; 47(20):1529-31. PubMed ID: 20092738
    [Abstract] [Full Text] [Related]

  • 27. Intraoperative radiofrequency ablation for hepatocellular carcinoma: long-term results in a large series.
    Kim YS, Rhim H, Lim HK, Choi D, Lee WJ, Jeon TY, Joh JW, Kim SJ.
    Ann Surg Oncol; 2008 Jul 15; 15(7):1862-70. PubMed ID: 18463926
    [Abstract] [Full Text] [Related]

  • 28. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
    Seo JY, Kim W, Kwon JH, Jin EH, Yu SJ, Kim HY, Jung YJ, Kim D, Kim YJ, Yoon JH, Lee HS.
    Liver Int; 2013 Jul 15; 33(6):884-93. PubMed ID: 23461618
    [Abstract] [Full Text] [Related]

  • 29. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G.
    Eur J Gastroenterol Hepatol; 2008 Mar 15; 20(3):196-201. PubMed ID: 18301300
    [Abstract] [Full Text] [Related]

  • 30. [The factors related to the prognosis of solitary hepatocellular carcinoma after radiofrequency ablation].
    Chung IK, Park MJ, Kwon KT, Park YD, Chung YJ, Jeon SW, Lee MK, Seo HE, Lee YD, Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH.
    Korean J Hepatol; 2005 Dec 15; 11(4):371-80. PubMed ID: 16380666
    [Abstract] [Full Text] [Related]

  • 31. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
    Chow DH, Sinn LH, Ng KK, Lam CM, Yuen J, Fan ST, Poon RT.
    J Surg Oncol; 2006 Dec 01; 94(7):565-71. PubMed ID: 17048238
    [Abstract] [Full Text] [Related]

  • 32. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J, Chen MH, Yang W, Wu W, Yan K.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr 01; 20(4):256-60. PubMed ID: 22964144
    [Abstract] [Full Text] [Related]

  • 33. Risk factors for early intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma in Egyptian patients.
    Montasser MF, Shaker MK, Albreedy AM, Montasser IF, El Dorry A.
    J Dig Dis; 2014 Dec 01; 15(12):676-83. PubMed ID: 25214183
    [Abstract] [Full Text] [Related]

  • 34. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization.
    Fuke H, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Takaki H, Nakatsuka A, Yamakado K, Takeda K, Takei Y.
    Aliment Pharmacol Ther; 2008 Jun 01; 27(12):1253-60. PubMed ID: 18221404
    [Abstract] [Full Text] [Related]

  • 35. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation.
    Yang B, Zou J, Xia J, Ren Z, Gan Y, Wang Y, Zhang B, Ge N, Wang D, Chen Y, Chen R, Li L, Ye S, Wang X.
    Eur J Radiol; 2011 Aug 01; 79(2):196-200. PubMed ID: 20303686
    [Abstract] [Full Text] [Related]

  • 36. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
    Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI.
    Radiology; 2014 Mar 01; 270(3):900-9. PubMed ID: 24475823
    [Abstract] [Full Text] [Related]

  • 37. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
    Choi D, Lim HK, Kim MJ, Lee SH, Kim SH, Lee WJ, Lim JH, Joh JW, Kim YI.
    Radiology; 2004 Jan 01; 230(1):135-41. PubMed ID: 14631050
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M.
    Liver Int; 2004 Dec 01; 24(6):625-9. PubMed ID: 15566514
    [Abstract] [Full Text] [Related]

  • 39. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, Curley SA, Zorzi D, Abdalla EK.
    Arch Surg; 2006 May 01; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [Abstract] [Full Text] [Related]

  • 40. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.
    Kudo M, Sakaguchi Y, Chung H, Hatanaka K, Hagiwara S, Ishikawa E, Takahashi S, Kitai S, Inoue T, Minami Y, Ueshima K.
    Oncology; 2007 May 01; 72 Suppl 1():132-8. PubMed ID: 18087194
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.